These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2465771)

  • 1. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.
    Goudsmit J
    AIDS; 1988; 2 Suppl 1():S41-5. PubMed ID: 2465771
    [No Abstract]   [Full Text] [Related]  

  • 2. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
    Snart RS
    AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune response to viral peptides in patients exposed to HIV.
    Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
    Papsidero LD; Poiesz BJ; Montagna RA
    Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strains.
    Zvelebil MJ; Sternberg MJ; Cookson J; Coates AR
    FEBS Lett; 1988 Dec; 242(1):9-21. PubMed ID: 2462515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
    Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays.
    Böltz T; Hummel RP; Tröger W; Rübsamen-Waigmann H; Biesert L; Müller-Lantzsch N; Koch P; Bessler W; Jung G
    J Virol Methods; 1988 Dec; 22(2-3):173-82. PubMed ID: 2464607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1.
    Modrow S; Höflacher B; Mellert W; Erfle V; Wahren B; Wolf H
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):21-7. PubMed ID: 2537398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
    Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
    J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
    Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
    J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of linear B-cell epitopes in the C1, V1, and V3 region of HIV-1 gp 120.
    van Tijn DA; Boucher CA; Bakker M; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1989; 2(3):303-6. PubMed ID: 2470894
    [No Abstract]   [Full Text] [Related]  

  • 14. Part of AIDS virus is patented.
    Sun M
    Science; 1988 Feb; 239(4843):970. PubMed ID: 2830668
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of antigenaemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state.
    Re MC; Furlini G; La Placa M
    J Clin Pathol; 1989 Mar; 42(3):282-3. PubMed ID: 2703545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines and immunology. Overview.
    Laurence J
    AIDS; 1988; 2 Suppl 1():S91-4. PubMed ID: 2852505
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-gag-specific cytotoxic T lymphocytes.
    Nixon DF; McMichael AJ
    Res Immunol; 1989 Jan; 140(1):107-10; discussion 121. PubMed ID: 2657907
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of T- and B-cell epitopes of a simian retrovirus (SRV-2) envelope protein.
    Malley A; Werner L; Benjamini E; Leung CY; Torres J; Pangares N; Shiigi S; Axthelm M
    J Med Primatol; 1991 Jun; 20(4):177-81. PubMed ID: 1719205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.